CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (AMEX: JAV) today announced that Chief Executive Officer, Martin J. Driscoll, will give a corporate overview, including a discussion of the company’s commercial and clinical programs at BioCentury’s NewsMakers in the Biotech Industry Conference at 11:30am ET on September 4, 2008. The conference is being held at the Millennium Broadway Hotel – 145 W. 45th Street in New York City.
